next steps for cabozantinib plus durvalumab in gi cancer
Published 2 years ago • 122 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
2:06
camilla: phase i/ii study of cabozantinib plus durvalumab in advanced ge cancer and gi malignancies
-
0:54
interim results from arcadia trial: cabozantinib plus durvalumab in advanced urothelial carcinoma
-
1:30
camilla: combining a vegf tki with immune checkpoint inhibitors for ge and gi cancer
-
1:21
future directions of camilla trial
-
2:34
cabozantinib demonstrates disease control in advanced adrenocortical carcinoma
-
2:55
systemic immune response to durvalumab concomitant with neoadjuvant chemotherapy in early stage tncb
-
3:00
biomarker-directed biscay data: durvalumab plus targeted therapies in muc
-
1:27
next steps in breast cancer: de-escalation & immunotherapy
-
6:04
durvalumab plus chemotherapy significantly improved os in advanced biliary tract cancer
-
7:23
durvalumab plus bevacizumab, added to tace, shows benefit for unresectable hepatocellular carcinoma
-
3:53
cabozantinib in combination with immunotherapy for advanced renal cell carcinoma
-
4:11
what's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
-
3:56
cabozantinib as immune modulatory therapy for advanced rcc
-
5:13
effectively managing treatment with durvalumab
-
1:29
updated results for pacific trial establish new standard of care in lung cancer
-
8:28
outcomes for patients with locally advanced head and neck cancer receiving neoadjuvant pembrolizumab
-
2:27
hnrnpab:a key molecule in early metastasis of pancreatic ductal adenocarcinomas
-
1:45
enhancing benefit with durvalumab in nsclc after the pacific trial
-
2:45
sequence: nab-paclitaxel/gemcitabine with modified folfox in pancreatic cancer